This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Strand Life Sciences Pvt Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Anupama Rajan Bhat: Innovator in Organ Toxicity Prediction
Introduction
Anupama Rajan Bhat is a notable inventor based in Bhavnagar, India. She has made significant contributions to the field of drug development through her innovative research. Her work focuses on predicting organ toxicity, which is crucial for ensuring the safety and efficacy of new pharmaceuticals.
Latest Patents
Anupama holds a patent titled "Method for predicting organ toxicity and a system thereof." This patent describes a systems approach that utilizes mathematical modeling of essential biochemical pathways involved in organ homeostasis. By coupling this in silico model with in-vitro and/or in-vivo measurements, it allows for the accurate prediction of drug-induced organ injury. The method also demonstrates the capability to model various physiological situations, enhancing its applicability in drug development.
Career Highlights
Anupama is currently associated with Strand Life Sciences Pvt Ltd, where she continues to advance her research in organ toxicity prediction. Her work has the potential to revolutionize the way drug safety is assessed, leading to more informed decision-making in the pharmaceutical industry.
Collaborations
Anupama collaborates with esteemed colleagues such as Kalyanasundaram Subramanian and Sowmya Raghavan, who contribute to her research endeavors. Their combined expertise fosters a collaborative environment that enhances the quality and impact of their work.
Conclusion
Anupama Rajan Bhat is a pioneering inventor whose work in predicting organ toxicity is paving the way for safer drug development. Her innovative methods and collaborative spirit are making significant strides in the field of pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile